February, 14, 2006 - Virginia Commonwealth University -

Levitra becomes the second drug after Viagra, having the potential to prevent heart diseases and protect the heart tissues from damage, which may lead to heart attacks. That is the result of the recent study, conducted by the group of scientists from the Virginia Commonwealth University (VCU).

The author of the study, Rakesh C. Kukreja, Ph.D, described the importance of the study results as follows: “Our findings further support the concept that the novel class of phosphodiesterase-5 inhibitors, or PDE-5 inhibitors, including Levitra and Viagra, may have a new utility in cardiac protection, in addition to their well-known use for the management of erectile dysfunction in men”.

The study demonstrated that treatment with Levitra not only improves men's sexual function by increasing the ability of male penis to erect, but also has a protective effect against heart attack injury. Levitra is said to be able to improve the process of converting oxygen into ATP in cardiac cells that is vitally important for normal functioning of human heart.

ATP is an abbreviation for adenosine triphosphate, a high energy phosphate molecule used to store and release energy for work within the body.

Taking into account the effectiveness of modern impotence pills (Viagra, Levitra and Cialis) in dilation of blood arteries by inhibiting PDE-5 enzymes, the scientists believe that these medications may soon become an additional option for those patients, who require certain optimization for their heart protective programs.

Moreover, Kukreja suggested that PDE-5 inhibitors may be developed further to protect other human organs, such as brain and liver that suffer from the lack of oxygen.

It is interesting to note, that in April, 2005, the study in Virginia Commonwealth University showed that Viagra, which is the first approved pill against erectile dysfunction, may significantly protect the heart muscle. That study demonstrated the potential of Viagra to decrease the harmful influence of chemotherapy on the heart muscle during treatment of breast cancer, leukemia and sarcomas.

So, according to the recent study from VCU, Levitra becomes the second PDE-5 inhibitor after Viagra, which has the potential not only to treat male impotence, but also to protect human heart and prevent serious heart diseases.

Nick

---

External resources
http://www.vcu.edu/uns/Releases/2006/feb/021406.html

(C) ePillz.com, All rights reserved.
This material may not be published, broadcast, rewritten, or redistributed in any form.

Your Feedback for This Article

Nickname: Input code the below: